Seed Investor · Clinical Trials Veteran · Biotech Analyst
Backing the infrastructure of clinical medicine — before the rest of the market knows it exists.
01 — Investment Thesis
The clinical trial and regulatory ecosystem is massively under-tooled. I've spent 21 years on the ground — site management, protocol design, FDA interactions, sponsor negotiations. I've watched billion-dollar drugs fail not because the science broke down, but because operations did: data errors, site dropout, patient retention failures, communication gaps that everyone accepted as just part of the job.
The normalized workaround is exactly where the biggest companies get built. When everyone treats the pain as inevitable, the person who removes it looks like a miracle worker. Most software in this space was built by people who never ran a trial — Veeva came from Salesforce. The exceptions — Creo, Realtime, Yisa — were built by operators who lived the problems first. That difference shows in the product.
Jensen Huang said the new programming language is English. The cost of building has collapsed. The scarcity now isn't technical ability — it's operator knowledge. The accumulated frustration of someone who has been in the room. That intel no VC can buy reading research reports, and no academic framework captures. I write a Substack read by 10,000+ retail biotech investors. I build free tools like this PDUFA calendar. My angle is earned from the inside.
02 — Focus Areas
03 — Why It Matters
04 — Portfolio
Browser extension that automates data entry for clinical research sites. Gleam lets site staff copy source data from any eSource directly into EDC CRFs — fast, accurate, and without the transcription errors that create downstream audit findings. YC S23.
Enables non-investigator treating physicians to host clinical trial appointments from their local practices without becoming investigators. MedVector keeps patients in their trusted provider's office — unlocking a pool of enrolled candidates that traditional site networks can't reach.
AI-powered patient navigator for clinical trial recruitment and matching. PatientAce connects patients who qualify for trials with sites actively enrolling — reducing the median time-to-first-patient-in.
Infrastructure and support network for independent clinical trial sites. Site sustainability is a real crisis — qualified investigators are leaving the business. Save Our Sites builds the operational backbone to keep them viable.
Data-driven site selection platform for clinical trial sponsors. SelectIQ uses enrollment history, therapeutic area expertise, and real-time capacity data to match sponsors with the sites most likely to deliver.
Browser extension providing bookmark management, feasibility tracking, and collaboration tools for clinical research site teams. Built for coordinators managing multiple concurrent studies. Advisory board. Acquired by Florence Healthcare in September 2023.
Clinical trial site coordination platform built to reduce the operational drag that stalls enrollment. Coordinare streamlines communication, task management, and document workflows between sites and sponsors — targeting the coordination failures that account for most preventable trial delays.
05 — Get in Touch
If you're building at the intersection of clinical operations, regulatory strategy, or patient technology — I want to hear from you.
I look at pre-seed and seed rounds. I'm most useful to founders who need someone who's actually been in the room — FDA meetings, site visits, sponsor negotiations, protocol reviews. Check/wire amounts are modest; time and pattern-matching are the real value.
If you're a GP, LP, or angel looking to co-invest alongside deep domain expertise in clinical research, I'm interested in that conversation too. Capital that knows what it's backing moves faster and makes better decisions. This space needs more of it.
Twitter DMs and email are the fastest paths in.